DARE 8-K 2026-10-01

Dare Bioscience, Inc. (DARE) 8-K dated 2026-10-01 — accession 0001493152-26-045275. This URL is the filing, not the DARE hub.

Dare Bioscience, Inc. (DARE) is a biotechnology company listed on US.

Dare Bioscience, Inc. filed a 8-K on 2026-10-01. Accession 0001493152-26-045275.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported DARE revenue for 2025-12-31 was $1.0M. Net income was -$13.4M. Revenue was up 10429.4% from 2024-12-31 to 2025-12-31. DARE currently screens at market cap $21.2M.

Not investment advice. The DARE SEC hub lists recent forms. The stock page is the research view.